New hope for seniors: targeted chemo may beat standard treatment for advanced colorectal cancer
NCT ID NCT07209384
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether delivering chemotherapy directly to the liver (transarterial chemoembolization) works better and causes fewer side effects than standard IV chemotherapy in people aged 65 and older with advanced colorectal cancer that cannot be removed by surgery. About 50 participants will receive either the targeted approach or standard treatment, with or without additional targeted drugs. The goal is to see if the targeted method shrinks tumors more effectively and controls the disease longer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ELDERLY (PEOPLE AGED 65 OR MORE) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.